EUVIMEDEUVIMED entdecken
Crossref

Luteolin reverses chemoresistance in colorectal cancer cells via TET1/TDG-dependent epigenetic repression of β-catenin

Kyoung Ah Kang, Mei Jing Piao, Herath Mudiyanselage Maheshika Madhuwanthi Senavirathna, Mahadurage Pasindu Laksara Madhuwantha, Hye-Jin Boo, Sang Pil Yoon, Yung Hyun Choi, Young Ree Kim, Jin Won Hyun

Food and Chemical Toxicology · 2026-10 · 216 · 116296

DOI: 10.1016/j.fct.2026.116296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-10. Verfasst von Kyoung Ah Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, and Jeju Research Center for Natural Medicine, Jeju National University, Jeju, 63243, Republic of Korea. Hauptthemen laut MEDLINE: Luteolin, beta Catenin, Colorectal Neoplasms, Proto-Oncogene Proteins. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Research Foundation of Korea, Jeju National University Hospital, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to 5-fluorouracil (5-FU) and oxaliplatin (OXT) remains a major cause of treatment failure in colorectal cancer (CRC). Luteolin, a dietary flavonoid with anticancer properties, has shown therapeutic potential in various malignancies, but its effects on chemotherapy-resistant CRC remain poorly understood. In this study, we investigated whether luteolin restores chemosensitivity in 5-FU-resistant (SNUC5/5-FUR) and OXT-resistant (SNUC5/OXTR) CRC cells and explored the underlying molecular mechanisms. Luteolin reduced cell viability and induced apoptosis in both resistant cell lines. Mechanistically, luteolin suppressed β-catenin expression by downregulating ten-eleven translocation (TET) proteins, increasing DNA methyltransferase (DNMT) expression, enhancing CpG methylation, and reducing TET1 occupancy at the β-catenin promoter. Luteolin also decreased thymine DNA glycosylase (TDG) expression, disrupted the TET1/TDG interaction, and reduced TDG recruitment to the β-catenin promoter. Consistently, knockdown of either TET1 or TDG decreased β-catenin expression, while luteolin further enhanced apoptosis in siTET1-or siTDG-transfected resistant cells. Additionally, luteolin attenuated intracellular reactive oxygen species accumulation and potentiated the cytotoxic effects of 5-FU and OXT in resistant CRC cells. These findings demonstrate that luteolin reverses chemoresistance by suppressing the TET1/TDG-β-catenin axis through epigenetic regulation and modulation of intracellular redox homeostasis, supporting its potential as an adjuvant for CRC chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Luteolinbeta CateninColorectal NeoplasmsProto-Oncogene ProteinsDrug Resistance, NeoplasmEpigenesis, GeneticMixed Function OxygenasesAntineoplastic AgentsHumansCell Line, TumorApoptosisFluorouracilGene Expression Regulation, NeoplasticCell SurvivalDNA Methylation

Stichwörter der Autor:innen

ChemoresistanceLuteolinReactive oxygen speciesTET1/TDG axisβ-Catenin

Substanzen

Luteolinbeta CateninProto-Oncogene ProteinsTET1 protein, humanMixed Function OxygenasesFluorouracilAntineoplastic Agents

Autor:innen und Institutionen

  • College of Medicine, and Jeju Research Center for Natural Medicine, Jeju National University, Jeju, 63243, Republic of Korea.
  • Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan, 47227, Republic of Korea.
  • Department of Laboratory Medicine, Jeju National University Hospital, and College of Medicine, Jeju National University, Jeju, 63241, Republic of Korea. Electronic address: namu8790@jejunu.ac.kr.
  • College of Medicine, and Jeju Research Center for Natural Medicine, Jeju National University, Jeju, 63243, Republic of Korea. Electronic address: jinwonh@jejunu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Jeju National University Hospital
  • Ministry of Education

Zitieren

APA

Kang, K. A., Piao, M. J., Senavirathna, H. M. M. M., Madhuwantha, M. P. L., Boo, H. J., Yoon, S. P., Choi, Y. H., Kim, Y. R., & Hyun, J. W. (2026). Luteolin reverses chemoresistance in colorectal cancer cells via TET1/TDG-dependent epigenetic repression of β-catenin. Food and Chemical Toxicology, 216, 116296. https://doi.org/10.1016/j.fct.2026.116296

Vancouver

Kang KA, Piao MJ, Senavirathna HMMM, Madhuwantha MPL, Boo HJ, Yoon SP, et al. Luteolin reverses chemoresistance in colorectal cancer cells via TET1/TDG-dependent epigenetic repression of β-catenin. Food and Chemical Toxicology. 2026;216:116296. doi:10.1016/j.fct.2026.116296

BibTeX
@article{Kang2026,
  author = {Kang, Kyoung Ah and Piao, Mei Jing and Senavirathna, Herath Mudiyanselage Maheshika Madhuwanthi and Madhuwantha, Mahadurage Pasindu Laksara and Boo, Hye-Jin and Yoon, Sang Pil and Choi, Yung Hyun and Kim, Young Ree and Hyun, Jin Won},
  title = {Luteolin reverses chemoresistance in colorectal cancer cells via TET1/TDG-dependent epigenetic repression of β-catenin},
  journal = {Food and Chemical Toxicology},
  year = {2026},
  volume = {216},
  pages = {116296},
  doi = {10.1016/j.fct.2026.116296}
}
Kostenlos starten →